Harnessing Natural Killer Immunity in Metastatic SCLC
Open Access
- 1 September 2020
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 15 (9) , 1507-1521
Abstract
No abstract availableKeywords
Funding Information
- Victorian Cancer Agency
- National Health and Medical Research Council
- Cure Cancer Australia Foundation
This publication has 52 references indexed in Scilit:
- Signatures of mutational processes in human cancerNature, 2013
- Small-cell lung cancerThe Lancet, 2011
- Cell of Origin of Small Cell Lung Cancer: Inactivation of Trp53 and Rb1 in Distinct Cell Types of Adult Mouse LungCancer Cell, 2011
- Loss of p130 Accelerates Tumor Development in a Mouse Model for Human Small-Cell Lung CarcinomaCancer Research, 2010
- Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinaseNature Protocols, 2009
- TGF-β type II receptor–deficient thymocytes develop normally but demonstrate increased CD8+ proliferation in vivoBlood, 2005
- affy—analysis of Affymetrix GeneChip data at the probe levelBioinformatics, 2004
- Summaries of Affymetrix GeneChip probe level dataNucleic Acids Research, 2003
- Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient miceNature, 1994
- Multiple Defects of Immune Cell Function in Mice with Disrupted Interferon-γ GenesScience, 1993